Top Markets
#1 Black Phoenix Black Phoenix +355.20%
#2 Glidr Glidr +84.34%
#3 Gold Park Gold Park +62.60%
#4 Akedo Akedo +60.88%
#5 OpenEden OpenEden +54.74%
#6 Acurast Acurast +29.22%
#7 BasedHype BasedHype +27.20%
#8 Cryptopia Cryptopia +21.54%
#9 Avantis Avantis +18.96%
#10 Ether.fi Ether.fi +17.29%
Coin of the day
Black Phoenix Black Phoenix
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
BiVictriX Therapeutics Plc BiVictriX Therapeutics Plc

BiVictriX Therapeutics Plc

BVX
Kedudukan dalam Saham #40613
BiVictriX Therapeutics Plc is a United Kingdom-based biotechnology firm... BiVictriX Therapeutics Plc is a United Kingdom-based biotechnology firm dedicated to pioneering innovative treatments for cancer. The company's core technology involves its distinctive Bi-Cygni therapeutics, which are engineered to precisely identify and combat specific cancer types. Their foremost development program, BVX001, is currently being advanced to address acute myeloid leukaemia. Established in 2016 as BiVictriX Plc, the organization officially adopted its present name, BiVictriX Therapeutics Plc, in August 2021. Its corporate headquarters are located in Macclesfield, United Kingdom.
Harga Saham
$0.13607016
Disegerakkan terakhir: 2024-09-10
Modal Pasaran
$112.29K
Perubahan (1 hari)
22.46%
Perubahan (1 tahun)
0.00%
Negara
GB
Perdagangan BiVictriX Therapeutics Plc (BVX)

Kategori

Healthcare
Sejarah harga saham bagi BiVictriX Therapeutics Plc (BVX)
Harga penutupan tertinggi: $0.11 pada 2024-09-01

Harga penutupan terendah: $0.30 pada 2021-08-01
Sejarah harga saham BiVictriX Therapeutics Plc dari 2021 hingga 2026
Prestasi harga saham tahunan
Tahun Prestasi
2024 -21.63%
2023 -33.60%
2022 -41.42%
2021 0.00%
Harga saham bagi syarikat atau pesaing serupa
Syarikat Harga saham Perubahan 1thn% Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $517.18 30.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $857.76 32.66%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $744.96 8.94%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.08K -6.68%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $259.89 16.65%
BE